✦ LIBER ✦

Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment

✍ Scribed by E. Tsochatzis; G.V. Papatheodoridis; I. Elefsiniotis; S. Thanelas; G. Theodossiades; A. Moulakakis; A.J. Archimandritis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of recombinant activated factor

✍ JEFFERY HANRAHAN; PRASAD MATHEW 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

CASE REPORT: Use of Activated Recombinan

✍ Abhinandana Anantharaju; Kapil Mehta; Ayse L. Mindikoglu; David H. Van Thiel 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 497 KB

Use of recombinant activated factor VII

✍ GREGORY B. HAMMER; GLYN D. WILLIAMS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB

Prophylactic effect of recombinant facto

✍ Natascha C. J. Mathijssen; Rosalinde Masereeuw; Kitty Verbeek; J. Maurice Laverg 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

The use of activated recombinant coagula

✍ R. González-Boullosa; R. Ocampo-Martínez; M. J. Alarcón-Martín; M. Suárez-Rodríg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

The use of recombinant activated factor

✍ Weei-Yuarn Huang; Margot S. Kruskall; Kenneth A. Bauer; Lynne Uhl; Beth H. Shaz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB